Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study

被引：0
|
作者：
Mayo, Samantha J. [1 ,2 ]
Edelstein, Kim [2 ]
Bernstein, Lori [2 ]
Coley, Tiana [3 ]
Morrison, Stacey [2 ]
Vijenthira, Abi [3 ]
Maganti, Manjula [4 ]
Kuruvilla, John [3 ]
Crump, Michael [3 ]
Bhella, Sita D. [3 ]
Kridel, Robert [3 ]
Kukreti, Vishal [3 ]
Yang, Chloe [3 ]
Alibhai, Shabbir M. H. [2 ]
Chen, Christine [3 ]
Prica, Anca [3 ]
机构：
[1] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190650
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [2] Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Tan, Jia Yi
    Yeo, Yong Hao
    Kin, Hermon Wong Kha
    Ang, Qi Xuan
    Chisti, Mohammad Muhsin
    Ezekwudo, Daniel
    Hilal, Talal
    CANCER MEDICINE, 2025, 14 (06):
  • [3] Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
    Brammer, Jonathan E.
    Braunstein, Zachary
    Katapadi, Aashish
    Porter, Kyle
    Biersmith, Michael
    Guha, Avirup
    Vasu, Sumithira
    Yildiz, Vedat O.
    Smith, Sakima A.
    Buck, Benjamin
    Haddad, Devin
    Gumina, Richard
    William, Basem M.
    Penza, Sam
    Saad, Ayman
    Denlinger, Nathan
    Vallakati, Ajay
    Baliga, Ragavendra
    Benza, Raymond
    Binkley, Philip
    Wei, Lai
    Mocarski, Mason
    Devine, Steven M.
    Jaglowski, Samantha
    Addison, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [4] Longitudinal Patient-Reported Outcomes in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Johnson, Patrick Connor
    Dhawale, Tejaswini
    Lavoie, Mitchell W.
    Karpinski, Kyle
    Markovitz, Netana H.
    Hennessey, Kathleen
    Frigault, Matthew
    El-Jawahri, Areej
    BLOOD, 2022, 140 : 5232 - 5233
  • [5] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [6] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [7] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
    Habib, Ali
    Ciurea, Stefan
    Kamboh, Hafsa
    Miljkovic, Milos
    Mozaffar, Tahseen
    NEUROLOGY, 2024, 103 (07) : S119 - S120
  • [8] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [9] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [10] First Chimeric Antigen Receptor T-Cell Therapy Approved
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (11):
12345